Wellcome Trust is a UK-based medical research charity that funds research with the ultimate aim of protecting and improving human and animal health. They fund UK and international research.
| Company | Date | Round | Size | Participants |
| Nabriva Therapeutics | 1/10 | Series B | $22M | 4 |
| Oxagen | 11/09 | Series C | $26.7M | 9 |
| Integrated Diagnostics | 10/09 | Series A | $30M | 2 |
| Chroma Therapeutics | 6/09 | Unattributed | $24.5M | 6 |
| VaxInnate | 6/09 | Series D | $30M | 7 |
| Cell Biosciences | 4/09 | Series C | $10M | 7 |
| Qwell Pharmaceuticals | 1/09 | Series A | $7M | 2 |
| Lectus Therapeutics | 9/07 | Unattributed | £3M | 1 |
| Radius Health | 4/07 | Series B | $57.5M | 6 |
| Cell Medica | 3/07 | Unattributed | $3.74M | 2 |
| Sequoia Pharmaceuticals | 1/07 | Series C | $35M | 5 |
| Cell Biosciences | 2006 | Series B | $27M | 8 |
| Sirtris Pharmaceuticals | 3/05 | Series B | $27M | 6 |
| Sirtris Pharmaceuticals | 12/04 | Series A | $13M | 5 |